Difference between revisions of "Immunization Project"

From HL7Wiki
Jump to navigation Jump to search
(Archived first phase of immunization project)
Line 1: Line 1:
 
[[http://informatics.mayo.edu/wiki/index.php/Public_Health_and_Emergency_Response_SIG PHER main page]]
 
[[http://informatics.mayo.edu/wiki/index.php/Public_Health_and_Emergency_Response_SIG PHER main page]]
  
== Introduction ==
+
[[http://informatics.mayo.edu/wiki/index.php/Immunization_Project_%28archive%29 Immunization project phase 1 archive]]
  
 
+
Placeholder for new immunization projects: POIZ messaging and immunization DAM
This is the work-in-progress page for the HL7 v3 Immunization Project.  This project is a cross-committee effort, including external stakeholders, to define a broad "landscape" of use cases and requirements for the Immunization Domain.  The project will, in concert with all stakeholders, prioritize these requirements such to define an inital subset of requirements to be addressed by the first release of the v3 Immunization Domain.
 
 
 
== Contact Information ==
 
 
 
===HL7 email listserv===
 
    [mailto:immunization@lists.hl7.org immunization@lists.hl7.org]
 
          ([http://lists.hl7.org/read/?forum=immunization view archive])
 
          ([http://www.hl7.org/special/committees/list_sub.cfm?list=immunization subscribe])
 
 
 
===Project Leads===
 
    Scott M Robertson, PharmD
 
    Kaiser Permanente
 
    [mailto:scott.m.robertson@kp.org scott.m.robertson@kp.org]
 
 
 
    Rob Savage
 
    EDS
 
    [mailto:SavagRB@dhfs.state.wi.us SavagRB@dhfs.state.wi.us]
 
 
 
== Teleconference ==
 
===Schedule ===
 
:Date / Time(s)
 
::Call is scheduled for 1.0 hour
 
::Recurring weekly starting May 23 through Sept 5
 
 
 
::Tue 11:00 AM (US Eastern Time, GMT -5)
 
::Tue 08:00 AM (US Pacific Time, GMT -8)
 
::Tue 05:00 PM (Central Europe, GMT +1)
 
::Wed 02:00 AM (East Coast Australia, GMT +10)
 
 
 
:Participation Information
 
::Phone Number:        973-582-2813
 
::Participant Passcode: 654852
 
 
 
:Web: If in use for the current session,
 
::[https://lobby.mc.iconf.net/gcc/conferencing/partaccess.asp?ba=300000005 click here to join]
 
:::the meeting number is 3723229
 
::To test your broswer prior to the meeting, click          [http://lobby.mc.iconf.net/gcc/bt.asp?ba=300000005 here]
 
 
 
===Minutes===
 
:[[Media:20060523_Immunization_telcon.doc|23 May 2006]]
 
:[[Media:20060620_Immunization_telcon.doc|20 June 2006]]
 
:[[Media:20060627_Immunization_telcon.doc|27 June 2006]]
 
:[[Media:20060711_Immunization_telcon.doc|11 July 2006]]
 
 
 
== Project Scope Statement ==
 
 
 
[[Media:Immunization_Domain_Project_Scope_Statement_-_draft06.doc|Draft 06]]
 
 
 
== Use Case Survey==
 
===Files===
 
 
 
:[[Media:Immunization_Use_Case_Survey_-_form.zip|Survey Forms]] - Distributed to a variety of HL7 and non-HL7 groups in order to elicit as many different perspectives on the subject of Immunization
 
   
 
:[[Media:Immunization_Use_Case_Survey_-_received.zip|Responses]] - Survey responses received
 
 
 
:[[Media:Use_Case_Analysis-replica.zip|Use Case Analysis Database (zipped)]]  [[:Image:Use_Case_Analysis-replica.zip|(history)]]
 
::>>You can download this file and work off-line.  Send your work to Scott and it will be merged with the collective work.
 
::>>Please change 'replica' with your initials and current date when sending your off-line work
 
 
 
===Process===
 
 
 
:'''Send comments, questions and suggestions to [mailto:scott.m.robertson@kp.org Scott]'''
 
:06/26/2006 - First draft of documenting the process. 
 
 
 
#Consolidate Survey Results
 
##Create analysis database - '''Done'''
 
##Transcribe survey responses into database - '''Done'''
 
##Create seed lists for Actors and Use Cases - '''Done'''
 
##Demonstrate / Educate group on how to use the database - '''Ongoing'''
 
#Actor Normalization(can be concurrent with Use Case Normalization)
 
##Review submitted scenarios to identify actors in each scenario.  Can use actors developed from other scenarios or create new actors.  Little restraint on creating new actors.
 
##Review actors to look for similarities, variations, relationships.  In reviewing the derived actors, use the links back to the scenarios to assist in understanding the "intent" of the derived actor.
 
###Duplicates can be consolidated
 
###Variants should be clarified
 
###Relationships should be noted/defined
 
#Use Case Normalization(can be concurrent with Actor Normalization)
 
##Review submitted scenarios to identify use case(s) in each scenario.  Can use use case(s)developed from other scenarios or create new use case(s).  Little restraint on creating new use case(s).
 
##Review use case(s)to look for similarities, variations, relationships.  In reviewing the derived use case(s), use the links back to the scenarios to assist in understanding the "intent" of the derived use case(s).
 
###Duplicates can be consolidated
 
###Variants should be clarified
 
###Relationships should be noted/defined
 
#Report on Normalized Actors and Use Cases
 
##Submit normalized Actors and Use Cases to HL7 Immunization Group for comment and prioritization
 
##Submit normalized Actors and Use Cases to survey respondants for comment and prioritaztion
 
##Established priority list for Normalized Actors and Use Cases.
 
#Derive Message and Interaction requirements from Normalized Use Cases - (Process to be defined)
 
##TBD
 
#Cross-reference Requirements to available HL7 v3 artefacts - (Process to be defined)
 
##TBD
 

Revision as of 16:43, 18 September 2007

[PHER main page]

[Immunization project phase 1 archive]

Placeholder for new immunization projects: POIZ messaging and immunization DAM